Apretude 600 mg/3 mL (200 mg/mL) injection Images
Generic Name: cabotegravir
This medication has been identified as Apretude 600 mg/3 mL (200 mg/mL) injection. It is supplied by ViiV Healthcare.
Apretude is used in the treatment of Pre-Exposure Prophylaxis and belongs to the drug class integrase strand transfer inhibitor. Apretude 600 mg/3 mL (200 mg/mL) injection is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Apretude
- Generic Name
- cabotegravir
- Strength
- 600 mg/3 mL (200 mg/mL) injection
- Availability
- Prescription only
- Drug Class
- Integrase strand transfer inhibitor
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- ViiV Healthcare
- National Drug Code (NDC)
- 49702-0264
More about Apretude (cabotegravir)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: integrase strand transfer inhibitor
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.